<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02669589</url>
  </required_header>
  <id_info>
    <org_study_id>UKM 14_0066</org_study_id>
    <secondary_id>2014-004854-33</secondary_id>
    <secondary_id>03-AnIt-14</secondary_id>
    <nct_id>NCT02669589</nct_id>
  </id_info>
  <brief_title>Investigating Different Anticoagulants for Renal Replacement Therapy</brief_title>
  <acronym>RICH</acronym>
  <official_title>Regional Citrate Versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effect of regional citrate anticoagulation within
      the scope of continuous renal replacement (CRRT) in critically ill patients with acute kidney
      injury (AKI) on filter life span and 90-day all cause mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose of clinical trial:

      To evaluate the effect of regional citrate anticoagulation within the scope of continuous
      renal replacement (CRRT) in critically ill patients with acute kidney injury (AKI) on filter
      life span and 90-day all cause mortality.

      Patient population: critically ill patients with acute kidney injury requiring renal
      replacement therapy.

      Primary objective:

      Anticoagulation of the extracorporeal circuit is required in continuous RRT (CRRT). To this
      date, it is not clear which anticoagulant should be used for CRRT. Regional citrate
      anticoagulation (RCA) for CRRT in critically ill patients with AKI prolongs filter life span
      and reduces 90-day all cause mortality by approximately 8% (from 48% to 40%) compared to
      systemic heparin anticoagulation for CRRT
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CRRT-filter life span in hours</measure>
    <time_frame>during continuous renal replacement therapy up to 1 year</time_frame>
    <description>It will be reported how long the filter will be used during CRRT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival in a 90day follow-up period</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay in days</measure>
    <time_frame>up to 1 year</time_frame>
    <description>The primary ICU stay will be documented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay in days</measure>
    <time_frame>up to 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of renal replacement therapy</measure>
    <time_frame>1 year</time_frame>
    <description>within 1 year after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding complication</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with administration of red blood cells</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of infection</measure>
    <time_frame>during primary ICU stay up to 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse kidney events</measure>
    <time_frame>day 28, 60, 90 and after 1 year after start of CRRT</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of therapy</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery of renal function</measure>
    <time_frame>day 28, 60, 90 and 1 year after start of CRRT</time_frame>
    <description>The recovery of renal function will be defined as composite endpoint consisting of lack of dialysis dependency and serum creatinine level no more than 0.5 mg/dl above the baseline value)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with hemodialysis</measure>
    <time_frame>day 28, 60, 90 and 1 year after start of CRRT</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>day 28, 60 and 1-year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>SOFA Scores (Sepsis-related Organ Failure Assessment score)</measure>
    <time_frame>day 1-14, 21 and 28 during ICU stay</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>serum creatinine level in mg/dL</measure>
    <time_frame>Day 0, day 1, day 3, day 5 and 1 day after CRRT cessation</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>plasma urea concentration in mg/dl</measure>
    <time_frame>Day 0, day 1, day 3, day 5 and 1 day after CRRT cessation</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>glomerular filtration rate</measure>
    <time_frame>Day 0, day 1, day 3, day 5 and 1 day after CRRT cessation</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1450</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>heparin anticoagulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Systemic anticoagulation of the continuous renal replacement therapy with heparin.
Dose will be titrated to maintain aPTT (activated partial thromboplastin time) between 45-60s)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>citrate anticoagulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Regional anticoagulation of the continuous renal replacement therapy with citrate.
Target posthemofilter ionized calcium level: 0.25-0.35 mmol/l</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Heparin</intervention_name>
    <arm_group_label>heparin anticoagulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Citrate</intervention_name>
    <arm_group_label>citrate anticoagulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Critically ill patients with clinical indication for CRRT (clinical decision to use
             continuous RRT due to hemodynamic instability)

             Or

             Severe acute kidney injury (KDIGO 3-classification) despite optimal resuscitation

          2. At least one of the following conditions

               -  Sepsis or septic shock

               -  Use of catecholamines (norepinephrine or epinephrine ≥ 0.1 µg/kg/min or
                  norepinephrine ≥ 0.05 µg/kg/min + dobutamine (any dose) or norepinephrine ≥ 0.05
                  µg/kg/min + vasopressin (any dose) or epinephrine ≥ 0.05 µg/kg/min +
                  norepinephrine ≥ 0.05 µg/kg/min)

               -  Refractory fluid overload: worsening pulmonary edema: PaO2/FiO2 &lt; 300 mmHg and/or
                  fluid balance &gt; 10% of body weight)

          3. 18-90 years old

          4. Intention to provide full intensive care treatment for at least 3 days

          5. Written informed consent of the patient or the legal representatives or the authorized
             representative or the inclusion due to an emergency situation

        Exclusion Criteria:

          1. Patients with increased bleeding risk (e.g. an active bleeding from ulcers in the
             gastro-intestinal tract, hypertension with a diastolic blood pressure higher than 105
             mm Hg, injuries (intracranial hemorrhage, aneurysm of brain arteries) of or surgical
             procedures on the central nervous system if a heparinization with a target aPTT 45-60
             s is not allowed by the treating neurologist or neurosurgeon, severe retinopathies,
             bleeding into the vitreum, ophthalmic surgical procedures)) or injuries, active
             tuberculosis; infective endocarditis)

          2. Disease or organ damage related with hemorrhagic diathesis (coagulopathy,
             thrombocytopenia, severe liver or pancreas disease)

          3. Dialysis-dependent chronic kidney insufficiency

          4. Need of therapeutic systemic anticoagulation

          5. Allergic reaction to one of the anticoagulants or ingredients, Heparin-induced
             thrombocytopenia

          6. AKI caused by permanent occlusion or surgical lesion of the renal artery

          7. AKI caused by (glomerulo)nephritis, interstitial nephritis, vasculitis or postrenal
             obstruction

          8. Do-not-resuscitate order

          9. Hemolytic-uremic syndrome/thrombotic thrombocytopenic purpura

         10. Persistent and severe lactate acidosis in the context of an acute liver failure and/or
             shock

         11. Kidney transplant within the last 12 months

         12. Pregnancy and nursing period

         13. Abortus imminens

         14. No hemofiltration machine free for use at the moment of inclusion

         15. Participation in another clinical intervention trial in the last 3 months

         16. Persons with any kind of dependency on the investigator or employed by the sponsor or
             investigator

         17. Persons held in an institution by legal or official order
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Zarbock, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Muenster</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Zarbock, MD</last_name>
    <phone>+49-251</phone>
    <phone_ext>47255</phone_ext>
    <email>rich@anit.uni-muenster.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>D-52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>D-86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinikum Bad Saarow, Dept. of Intensive Care</name>
      <address>
        <city>Bad Saarow</city>
        <zip>D-15526</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charité Berlin, Dept. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charité Berlin CCM, Medical Department, Division of Nephrology</name>
      <address>
        <city>Berlin</city>
        <zip>D-10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charité Berlin CCV, Medical Department, Division of Nephrology</name>
      <address>
        <city>Berlin</city>
        <zip>D-13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Evangelisches Klinikum Bethel gGmbH</name>
      <address>
        <city>Bielefeld</city>
        <zip>D-33617</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Knappschaftskrankenhaus Bochum</name>
      <address>
        <city>Bochum</city>
        <zip>D-44892</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Bonn, Dept.of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Bonn</city>
        <zip>D-53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Duesseldorf, Dept. of Anaesthesiology</name>
      <address>
        <city>Duesseldorf</city>
        <zip>D-40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Düsseldorf, Dept. of Nephrology</name>
      <address>
        <city>Düsseldorf</city>
        <zip>D-40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>D-91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Essen, Dept. for Nephrology</name>
      <address>
        <city>Essen</city>
        <zip>D-45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Frankfurt, Dept. of Anesthesiology, Intensive-Care Medicine and Pain Therapy</name>
      <address>
        <city>Frankfurt</city>
        <zip>D-60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Gießen, Dept. of Anesthesiology and Intensive Care</name>
      <address>
        <city>Gießen</city>
        <zip>D-35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medicine Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>D-17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medical Center Göttingen, Dept. for Anesthesiology</name>
      <address>
        <city>Göttingen</city>
        <zip>D-37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Halle, Dept. of Anesthesiology and Intensive Care</name>
      <address>
        <city>Halle (Saale)</city>
        <zip>D-06120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg-Eppendorf, Dept. of Intensive Care</name>
      <address>
        <city>Hamburg</city>
        <zip>D-20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Heidelberg, Dept. of Anesthesiology</name>
      <address>
        <city>Heidelberg</city>
        <zip>D-69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Jena, Dept. of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Jena</city>
        <zip>D-07747</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein, Campus Kiel, Dept. for Anaesthesiology and Intensive Care</name>
      <address>
        <city>Kiel</city>
        <zip>D-24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Köln-Merheim, Medizinische Klinik I</name>
      <address>
        <city>Köln</city>
        <zip>D-51109</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>D-04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>D-55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>D-48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Technical University of Munich University Hospital, Dept. for Anaesthesiology</name>
      <address>
        <city>München</city>
        <zip>D-81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Nürnberg</name>
      <address>
        <city>Nürnberg</city>
        <zip>D-90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Regensburg, Dept. of Surgery</name>
      <address>
        <city>Regensburg</city>
        <zip>D-93042</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Municipal Hospital Solingen, Dept. for Nephrology and General Internal Medicine</name>
      <address>
        <city>Solingen</city>
        <zip>D-42653</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>D-72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2016</study_first_submitted>
  <study_first_submitted_qc>January 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2016</study_first_posted>
  <last_update_submitted>January 29, 2018</last_update_submitted>
  <last_update_submitted_qc>January 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CRRT</keyword>
  <keyword>AKI</keyword>
  <keyword>anticoagulation</keyword>
  <keyword>KDIGO</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

